News
$Adicet Bio (ACET.US)$ The FDA Has Granted Fast Track Designation To Adicet Bio's ADI-270 For Metastatic/Advanced Clear Cell Renal Cell Carcinoma Patients Who Have Been Treated With An Immune Checkpoint Inhibitor And A Vascular Endothelial Growth Factor Inhibitor
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
